![Frank Thomas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Thomas
Presidente presso
SPERO THERAPEUTICS, INC.
Patrimonio netto: 180 010 $ in data 31/05/2026
Profilo
Frank E.
Thomas is Chairman at Spero Therapeutics, Inc. since 2025.
Holds director positions at Orchard Therapeutics North America and Larimar Therapeutics, Inc. since 2014.
Serves as President & Chief Operating Officer at Orchard Therapeutics (Europe) Ltd. since 2020.
Acts as President, Chief Operating & Financial Officer at Orchard Therapeutics Plc since 2018.
Formerly served as President, Chief Executive Officer & Director at Critical Therapeutics, Inc. from 2006 to 2008.
Worked as Controller & Finance Director at Mechanical Dynamics, Inc. from 1997 to 2000.
Served as Independent Director at Zafgen, Inc. Directed at Massachusetts Biotechnology Council from 2007 to 2015.
Held the role of Chief Financial Officer & VP-Investor Relations at Esperion Therapeutics, Inc. from 2000 to 2004.
Was Chief Operating Officer & Senior Vice President at Molecular Biometrics, Inc. from 2010 to 2011.
Principal at Arthur Andersen LLP from 1992 to 2000.
President & Chief Operating Officer at AMAG Pharmaceuticals, Inc. from 2016 to 2017.
Completed undergraduate education at the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 55.000 ( 0,09% ) | 155 650 $ | 31/05/2026 | |
| 19/05/2026 | 7.000 ( 0,01% ) | 24 360 $ | 31/05/2026 |
Posizioni attive di Frank Thomas
| Società | Posizione | Inizio |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Presidente | 10/01/2025 |
| ORCHARD THERAPEUTICS PLC | Presidente | 18/03/2020 |
| LARIMAR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2014 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Presidente | 17/03/2020 |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Frank Thomas
| Società | Posizione | Fine |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Amministratore Delegato | 14/05/2012 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direttore/Membro del Consiglio | 01/01/2015 |
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Direttore Finanziario/CFO | 18/01/2010 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Amministratore Delegato | 31/03/2008 |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Frank Thomas
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
93
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Mechanical Dynamics, Inc.
 Mechanical Dynamics, Inc. Information Technology ServicesTechnology Services Develops, markets, and supports virtual prototyping solutions | Technology Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Commercial Services |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
